Medy-Tox Inc (086900)
KOSDAQ · Korea · prices in KRW · close of 23 Oct 2026
Key indicators
| Last close | KRW 67,400.00 |
|---|---|
| 52-week range | 61,600.00 – 141,100.00 |
| Return, 1 month / 3 months | +0.0% / −5.7% |
| Return, 1 year / 3 years | −44.1% / −66.4% |
| Trend | Below its 200-day average |
| RSI (14) | 49 |
| Volatility (1 year) | 44.7% |
| Worst drawdown (1 year) | -54.2% |
| Average daily value traded | 1,665.00M KRW |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Medy-Tox Inc is a South Korean biopharmaceutical company that develops and makes botulinum toxin products. Its main offering is a botulinum toxin type A formulation used in aesthetic treatments to smooth facial wrinkles and in therapeutic applications such as muscle spasticity. The company supplies clinics, physicians and distributors, with a substantial part of its business in overseas markets, and it is based in Korea.
On this site Medy-Tox Inc appears as a stock on the KOSDAQ (Korea), code 086900, with prices in South Korean won (KRW). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Medy-Tox Inc (086900) trades on the KOSDAQ in Korea. It last closed at KRW 67,400.00 on 23 October 2026.
Its price-based Market X-Ray is 50 out of 100 (a fair price profile), ranking 939 of 1,832 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 44.1% and over the last three months it fell 5.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on KOSDAQ
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 33 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -28.4% | ||
| From 52-week high | -51.4% | ||
| Momentum | 34 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -5.7% | ||
| 6-month return | -37.1% | ||
| 12-month return, skipping the last month | -44.1% | ||
| Stability (higher is calmer) | 68 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 44.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -54.2% | ||
| Liquidity | 76 · Strong | Trades actively. | |
| Average daily value traded | 1,665.00M KRW | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −0.7% |
|---|---|
| 1 month | +0.0% |
| 3 months | −5.7% |
| 6 months | −37.1% |
| 1 year | −44.1% |
| 3 years | −66.4% |
| 5 years | −50.0% |
Signals
| 50-day / 200-day average | 69,164.00 / 94,088.50 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2,417.43 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Sep 2025 | KRW 1,200.0000 |
| 27 Sep 2024 | KRW 1,100.0000 |
| 26 Sep 2023 | KRW 1,100.0000 |
| 29 Sep 2022 | KRW 1,000.0001 |
| 29 Sep 2021 | KRW 1,102.5000 |
| 28 Sep 2020 | KRW 1,000.0002 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on KOSDAQ; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.